Edwin de Graaf
Amministratore Delegato presso Gilde Healthcare Partners BV
Provenienza dei contatti di primo grado di Edwin de Graaf
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Gilde Healthcare Partners BV
Gilde Healthcare Partners BV Investment ManagersFinance Gilde Healthcare Partners BV is a Private Equity/Venture Capital firm, a subsidiary of Gilde Healthcare Holding BV founded in 1999 by Pieter van der Meer and Edwin William de Graaf. Gilde Healthcare Partners BV is headquartered in Utrecht with additional office in Cambridge.
21
| Subsidiary | Investment Managers | 21 |
AM-Pharma Holding BV
AM-Pharma Holding BV Pharmaceuticals: MajorHealth Technology AM-Pharma Holding BV operates as a financial holding company with interests in the bio-medical sector. The company was founded by Rudd Brands and is headquartered in Bunnik, Netherlands.
12
| Subsidiary | Pharmaceuticals: Major | 12 |
Sanifit Therapeutics SA
Sanifit Therapeutics SA BiotechnologyHealth Technology Sanifit Therapeutics SA develops pharmaceuticals for calcification disorders. Its pipeline consists of treatments for calcification disorders, such as calciphylaxis and osteoporosis. The company was founded by Felix Grases in 2004 and is headquartered in Palma de Mallorca, Spain.
10
| Subsidiary | Biotechnology | 10 |
Gilde Investment Management BV
Gilde Investment Management BV Investment ManagersFinance Gilde Investment Management BV is an Independent Private Equity firm founded in 1982. Gilde Investment Management BV is headquartered in Utrecht.
7
| Private Company | Investment Managers | 7 |
Tagworks Pharmaceuticals BV
Tagworks Pharmaceuticals BV BiotechnologyHealth Technology Tagworks Pharmaceuticals BV is a Dutch precision therapy company that develops a new standard of care for patients suffering from severe diseases, including cancer. Tagworks Pharmaceuticals is based in and the Netherlands. The company leverages its technology platform, which is protected by a broad patent estate, to pioneer the click-to-release approach. Tagworks is developing a pipeline of click-cleavable therapies, including its lead program, TGW101, an antibody-drug conjugate targeting TAG72. The company's technology enables on-target activation of ADCs and immunomodulators, as well as off-target deactivation of radioimmunotherapies to enhance their therapeutic index. The company was founded in 2011 by Raffaella Rossin, Zach Taylor, Marc Robillard, and Marc Robillard has been the CEO since 2011.
7
| Holding Company | Biotechnology | 7 |
Gilde Healthcare Holding BV
Gilde Healthcare Holding BV Financial ConglomeratesFinance Gilde Healthcare Holding BV is an investment holding Dutch company. The private company is based in Utrecht, NL. and has subsidiaries in Australia, Netherlands, United States and Germany. The CEOs of the company are Edwin William de Graaf, Marc Olivier Perret.
1
| Private Company | Financial Conglomerates | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Edwin de Graaf tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
ROCHE HOLDING AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
H. LUNDBECK A/S | Pharmaceuticals: Major | Corporate Officer/Principal | |
TIGENIX NV | Medical Specialties | Director/Board Member Director/Board Member | |
ASANTE SOLUTIONS INC | Medical Specialties | Director/Board Member | |
AURA BIOSCIENCES, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Lundbeckfond Invest A/S
Lundbeckfond Invest A/S Investment ManagersFinance Lundbeckfond Invest A/S (Lundbeckfond Invest) is the investment management subsidiary of the Lundbeck Foundation in Denmark. Established in 1999, the firm is based in Copenhagen and manages the Lundbeck Foundation's investments, aiming for long-term, stable returns with moderate risk, such that the Foundation's net capital is not jeopardized and the Foundation is able to meet its commitments in terms of awarding grants and of laying a capital base for its subsidiaries. | Investment Managers | Director/Board Member | |
Lundbeck Foundation
Lundbeck Foundation Investment Trusts/Mutual FundsMiscellaneous Lundbeck Foundation maintains and expands the activities of the Lundbeck Group. It provides funding for scientific research. Its support of scientific activities takes place mainly through the financing of concrete scientific projects in the areas of biomedicine and natural sciences. The firm grants a number of stipends and fellowships, and also supports education and procurement activities in biomedical and natural sciences. The company was founded by Grete Lundbeck on March 4, 1954 and is headquartered in Copenhagen, Denmark. | Investment Trusts/Mutual Funds | Director/Board Member | |
University of Cambridge | College/University | Doctorate Degree Doctorate Degree | |
VALERIO THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
INSEAD | College/University | Masters Business Admin Masters Business Admin | |
Agendia NV
Agendia NV Medical/Nursing ServicesHealth Services Agendia NV discovers and develops products for clinical management of cancer. It operates as a commercial-stage molecular diagnostic company that focuses on the discovery, development, and commercialization of products to improve the quality of life for cancer patients. The company was founded by Rene Bernards and Laura van't Veer in 2003 and is headquartered in Amsterdam, the Netherlands. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
CropDesign NV
CropDesign NV Miscellaneous Commercial ServicesCommercial Services CropDesign NV develops traits for cereal crops. It delivers agronomic traits for the global commercial seed markets. The firm focuses on enhancing grain yield in crops such as corn and rice, and increasing biomass of energy crops. Its platform, TraitMill, lows evaluating the effect of genes on the performance of plants under different growing conditions, including drought and low nutrient stress. The company was founded in 1998 and is headquartered in Zwijnaarde, Blgium. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
ABLYNX | Biotechnology | Chairman Director/Board Member | |
Technical University of Denmark | College/University | Graduate Degree | |
NEXSTIM PLC | Medical Specialties | Director/Board Member | |
Roche Glycart AG
Roche Glycart AG Pharmaceuticals: MajorHealth Technology Roche Glycart AG discovers and develops drugs. It is active in the research and development of new potent antibody-based products for the treatment of unmet clinical needs such as cancer. It uses its proprietary set of technologies to endow therapeutic antibodies. The company has developed glycoengineering technology (GlycoMAb) to boost a natural mechanism of action of therapeutic antibodies developed to mediate target cell killing. The company was founded in 2000 and is headquartered in Zurich, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Erasmus University Rotterdam | College/University | Graduate Degree | |
University of Leiden | College/University | Graduate Degree Undergraduate Degree | |
University of Utrecht | College/University | Doctorate Degree Graduate Degree | |
University of Bocconi | College/University | Undergraduate Degree | |
Swiss Federal Institute of Technology | College/University | Doctorate Degree Graduate Degree | |
DPA GROUP N.V. | Personnel Services | Chairman Director/Board Member | |
Gilde Equity Management Benelux Partners BV
Gilde Equity Management Benelux Partners BV Financial ConglomeratesFinance Gilde Equity Management Benelux Partners BV provides investment services. The company is headquartered in Utrecht, the Netherlands. | Financial Conglomerates | Chief Executive Officer Chief Executive Officer | |
DYSIS Medical Ltd.
DYSIS Medical Ltd. Medical SpecialtiesHealth Technology DySIS Medical Ltd. designs, develops, manufactures, and markets medical imaging systems. Its imaging systems assist clinicians with non-invasive, in-vivo detection of cancerous and pre-cancerous lesions and provides tools to aid medical practitioners in the detection, grading, and documentation of cervical neoplasia. The company was founded by Costas Balas in 2002 and is headquartered in Livingston, the United Kingdom. | Medical Specialties | Director/Board Member | |
Ysios Capital Partners SGEIC SA
Ysios Capital Partners SGEIC SA Investment ManagersFinance Ysios Capital Partners SGEIC SA (Ysios Capital) is a venture capital firm founded in 2007 by Joël Jean Pierre Jean-Mairet, Julia Salaverría Monfort and Josep Lluís Sanfeliu Benet. The firm is headquartered in San Sabastian, Spain with additional office in Barcelona. | Investment Managers | Founder Private Equity Investor Private Equity Investor | |
AM-Pharma BV
AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Biotechnology | Chairman Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Chief Operating Officer Corporate Officer/Principal Corporate Officer/Principal | |
Niels Clauson-Kaas A/S
Niels Clauson-Kaas A/S Miscellaneous Commercial ServicesCommercial Services Niels Clauson-Kaas A/S provides research and experimental development services in the fields of natural sciences and engineering. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Kurma Partners SA
Kurma Partners SA Investment ManagersFinance Kurma Partners SA (KP) is an independent venture capital firm founded in 2009 by Thierry Laugel. The firm is headquartered in Paris, France. | Investment Managers | Corporate Officer/Principal Private Equity Investor | |
BIOM'UP | Medical Specialties | Director/Board Member | |
Lundbeckfonden Ventures
Lundbeckfonden Ventures Investment ManagersFinance Lundbeckfonden Ventures (Lundbeckfonden Ventures) is a venture capital firm wholly-owned by the Lundbeck Foundation. The firm was established in 2009 and is headquartered in Copenhagen, Denmark. | Investment Managers | Consultant / Advisor | |
STAT-Dx Life SL
STAT-Dx Life SL Medical SpecialtiesHealth Technology STAT-Dx Life SL focuses on the development, manufacturing and commercialization of diagnostic solutions for fast and accurate diagnostic results of infectious diseases and critical care. It solution offers DiagCORE Cartridge, for sample and analyzation of cell material, nucleic acid purification, amplification and hybridization process. The company was founded by Jordi Cabrrera Fabra and Rafael Bru Gibert in 2010 and is headquartered in Barcelona, Spain. | Medical Specialties | Director/Board Member Director/Board Member | |
SPERO THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Step Pharma SAS
Step Pharma SAS Pharmaceuticals: MajorHealth Technology Step Pharma SAS develops drugs for immunosuppressive therapies. The company was founded by Geoffroy de Ribains, Alain Fischer, and Sylvain Latour and is headquartered in Paris, France. | Pharmaceuticals: Major | Chairman Chairman | |
Varmx BV
Varmx BV BiotechnologyHealth Technology VarmX BV is a spin-off from Leiden University Medical Center (LUMC) founded in 2016 by Professor Pieter Reitsma, a world-leading expert in hemostasis and thrombosis. VarmX is based in Leiden, NL. The Dutch company's lead compound, VMX-C001, is a modified recombinant blood factor X developed for the treatment of severe spontaneous bleeding and for the prevention of bleeding during urgent surgery in patients taking oral factor Xa inhibitors (FXa DOACs) as anticoagulation therapy. The company is supported by a strong syndicate of investors. Jan K. Öhrström has been the CEO of the company since 2018. | Biotechnology | Director/Board Member | |
Gilde Equity Management (GEM) Benelux Partners BV
Gilde Equity Management (GEM) Benelux Partners BV Investment ManagersFinance Gilde Equity Management is a Private Equity firm founded in 1996. The firm is headquartered in Heemstede Estate, Netherlands. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
Center For Intelligent Research in Crystal Engineering SL
Center For Intelligent Research in Crystal Engineering SL Miscellaneous Commercial ServicesCommercial Services Center For Intelligent Research in Crystal Engineering SL is based in Palma, Spain. CIRCE Scientific, also known as the Center For Intelligent Research in Crystal Engineering SL, achieves improved health and longevity through scientifically enhanced active ingredients with its Cocrystal Engineering. The Spanish company was founded by Fernando Barrera and Rafel Prohens. Fernando Barrera has been the CEO since incorporation. | Miscellaneous Commercial Services | Chairman | |
SpliceBio SL
SpliceBio SL BiotechnologyHealth Technology SpliceBio SL is a genetic medicines company based in Barcelona, Spain. The Spanish company harnesses its proprietary protein splicing platform to develop the next generation of gene therapies. SpliceBio's platform offers the potential to address diseases that currently cannot be treated with gene therapies because the necessary gene is too large to be delivered by -associated virus (AAV) vectors. The company's lead program targets Stargardt disease, a genetic eye disease that causes vision loss in children and adults. SpliceBio's platform is based on technology developed in the Muir lab at Princeton University after more than 20 years of pioneering intein and protein engineering research. The company was founded by Dominguez Silvia Frutos, Miquel Vila-Perelló, and Miquel Vila-Perelló has been the CEO since incorporation. | Biotechnology | Director/Board Member Director/Board Member | |
LAVA THERAPEUTICS N.V. | Biotechnology | Director/Board Member Founder Director/Board Member Director/Board Member | |
ADCendo ApS
ADCendo ApS BiotechnologyHealth Technology ADCendo ApS is a Danish company that is focused on developing antibody-drug conjugates (ADCs) to treat underserved cancers. The company is based in Humlebaek, Denmark. The company completed a series A extension financing round in 2023, which brought its funds to 82 million EUR to advance into clinical development. The investors in the company include Novo Holdings, Ysios Capital, Pontifax Venture Capital, RA Capital Management, HealthCap, and Gilde Healthcare. The company was founded in 2017 by Christoffer Nielsen, Henrik Stage. Michael Pehl has been the CEO of the company since 2021. | Biotechnology | Director/Board Member Director/Board Member | |
NuMat Medtech SL
NuMat Medtech SL Miscellaneous Commercial ServicesCommercial Services NuMat Medtech SL engages in the development of coating technology for dental and orthopedic bone implants. It offers solutions based on natural molecules that improves functionalities on implants. The company was founded by Marta Monjo and Joana M. Ramis in 2016 and is headquartered in Palma de Mallorca, Spain. | Miscellaneous Commercial Services | Chairman | |
Tridek-One Therapeutics SAS
Tridek-One Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Tridek-One Therapeutics SAS is a French private biotechnology company founded in 2018. The company is based in Paris, France. Tridek-One's scientific founders at INSERM conducted groundbreaking research on the role of CD31 in the modulation of the immune response, which forms the basis of the company's work. The company was founded in 2019 by Giuseppina Caligiuri, Antonino Nicoletti, and the CEO is Laurence de Schoulepnikoff. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Ice Lake Capital Management BV
Ice Lake Capital Management BV Investment ManagersFinance Ice Lake Capital Management BV (IceLake Capital) is a private equity firm founded in 2018 by Bastiaan Hagenouw, Matteo Racca and Vincent Lüning. The firm is headquartered in Amsterdam, the Netherlands. | Investment Managers | Founder | |
Symeres BV
Symeres BV Pharmaceuticals: OtherHealth Technology Symeres provides molecule contract research, discovery, development and manufacturing services. The firm offers discovery chemistry, medicinal chemistry, early process research and GMP production services. The company is headquartered in Groningen, the Netherlands. | Pharmaceuticals: Other | Director/Board Member | |
Vico Therapeutics BV
Vico Therapeutics BV BiotechnologyHealth Technology Vico Therapeutics BV is a private biotech company based in Leiden, Netherlands that focuses on developing RNA modulating therapies for rare severe neurological disorders. The Dutch company's antisense oligonucleotide platform (AON) is directed towards different forms of spinocerebellar ataxia (SCA) and Huntington disease (HD), while its early discovery RNA editing platform is directed towards Rett syndrome. Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Gail Mandel, and Dr. Judith van Deutekom, who have strong academic reputations and vast industry experience. Micah Mackison has been the CEO of the company since 2022. | Biotechnology | Director/Board Member Director/Board Member | |
Synexa Life Sciences BV
Synexa Life Sciences BV BiotechnologyHealth Technology Synexa Life Sciences BV is a Dutch company that specializes in Biomarker and Bioanalysis Research Services. The company is based in Leiden, Netherlands. The company has expertise in designing and delivering biomarker strategies for biopharma clients. and has subsidiaries in Finland. The company was founded in 2003 by Justin Devine, Patrick Bouic, Paul O'Riordan. The CEO is Emile Lens. | Biotechnology | Director/Board Member Director/Board Member | |
Sound Bioventures Management ApS | Investment Managers | Founder |
Statistiche
Distribuzione geografica
Paesi Bassi | 15 |
Danimarca | 10 |
Francia | 8 |
Spagna | 6 |
Stati Uniti | 5 |
Settori
Health Technology | 25 |
Finance | 9 |
Consumer Services | 9 |
Commercial Services | 7 |
Miscellaneous | 2 |
Posizioni
Director/Board Member | 184 |
Corporate Officer/Principal | 60 |
Private Equity Investor | 54 |
Chairman | 37 |
Founder | 19 |
Contatti più connessi
Insiders | |
---|---|
Russell Greig | 31 |
Rémi Droller | 29 |
Guido Magni | 23 |
Ashok Dhanrajgir | 21 |
Christopher Martin | 18 |
Casper Breum | 18 |
Joël Jean-Mairet | 17 |
Geert-Jan Mulder | 17 |
Klaus Breiner | 16 |
Rita Jain | 14 |
Janke Dittmer | 13 |
Erik van den Berg | 13 |
Naveed Iqbal Siddiqi | 12 |
Pieter van der Meer | 12 |
Eline Blaauboer | 11 |
- Borsa valori
- Insiders
- Edwin de Graaf
- Connessioni Società